BIOAMBER INC - *W EXP 05/09/201 (BIOAWS)

CUSIP: 09072Q114

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / *W EXP 05/09/201
Total 13F shares
4,957,848
Share change
+8,421
Total reported value
$216,000
Price per share
$0.04
Number of holders
10
Value change
-$148,291
Number of buys
4
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 09072Q114?
CUSIP 09072Q114 identifies BIOAWS - BIOAMBER INC - *W EXP 05/09/201 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BIOAMBER INC - *W EXP 05/09/201 (BIOAWS) as of Q1 2017

As of 31 Mar 2017, BIOAMBER INC - *W EXP 05/09/201 (BIOAWS) was held by 10 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,957,848 shares. The largest 10 holders included WADDELL & REED FINANCIAL INC, ARROWGRASS CAPITAL PARTNERS (US) LP, MOORE CAPITAL MANAGEMENT, LP, LEVIN CAPITAL STRATEGIES, L.P., SOROS FUND MANAGEMENT LLC, K.J. Harrison & Partners Inc, Monashee Investment Management LLC, VERTEX ONE ASSET MANAGEMENT INC., SUSQUEHANNA INTERNATIONAL GROUP, LLP, and KCG HOLDINGS, INC.. This page lists 10 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.